Advance Directives and End-of-Life Care: Knowledge and Preferences of Patients with Brain Tumours from Anhui, China
Preprint
- 29 October 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: In Mainland China, the advance directives (ADs) and end-of-life care of patients with tumours, especially patients with brain tumours who may have lost consciousness or the ability to speak at the early stage of their illness, have been poorly acknowledged. Thus, this study aims to clarify the knowledge and preferences of the ADs and end-of-life care of patients with brain tumours and to investigate the predictors of patients’ preferences.Methods: This was a population-based cross-sectional survey that was conducted via face-to-face interviews. Information on the sociodemographic factors, brain tumour illness, knowledge and preferences of the advance decisions and end-of-life care of the patients were collected.Results: A total of 88.61% of the participants had never heard of ADs, but 65.18% would like to make ADs. Knowledge of ADs, receiving surgical treatment or radiotherapy, less than 70 years old, male, educational qualifications of college or beyond, childless, had medical insurance for nonworking or working urban residents and self-payment of medical expenses were predictors of preference for making ADs. A total of 79.43% participants would like to discuss end-of-life arrangements with medical staff, and 63.29% of participants were willing to receive end-of-life care although it could not delay death. A total of 65.82% patients with brain tumours wanted resuscitation, and as high as 45.45% of the patients thought that they did not need life support if they were in a persistent vegetative state. Brain primary tumours, ages of less than 70 years old, male, educational qualification of junior middle school or below, had children, had new rural cooperative medical insurance and had medical expenses paid by children or spouses were predictors of choosing appropriate palliative care.ConclusionsADs and end-of-life care have been poorly acknowledged amongst patients with brain tumours in mainland China. Additional efforts should be encouraged amongst patients with primary brain tumours, those are undergoing surgery and radiotherapy and those who have low socioeconomic status. A longitudinal and comprehensive study is encouraged to promote a disease-specific ADs amongst Chinese patients with brain tumours.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- End of life care for glioblastoma patients at a large academic cancer centerJournal of Neuro-Oncology, 2017
- Knowledge, attitudes, and influencing factors of cancer patients toward approving advance directives in ChinaSupportive Care in Cancer, 2016
- End-of-Life Care Intensity Among Adolescent and Young Adult Patients With Cancer in Kaiser Permanente Southern CaliforniaJAMA Oncology, 2015
- Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancerCancer, 2015
- Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care?Cancer, 2013
- Impact of radiotherapy delay on survival in glioblastomaClinical and Translational Oncology, 2012
- Identifying the palliative care needs of patients living with cerebral tumors and metastases: a retrospective analysisJournal of Neuro-Oncology, 2012
- Advance directives: prevalence and attitudes of cancer patients receiving radiotherapySupportive Care in Cancer, 2012
- Decision-making in the end-of-life phase of high-grade glioma patientsEuropean Journal of Cancer, 2012
- Preferences of elderly cancer patients in their advance directivesCritical Reviews in Oncology/Hematology, 2010